10.19.22
Identiv, Inc. announced the appointment of Laura Angelini and Richard Kuntz, MD, MSc. to its Board of Directors. Both directors bring unique medical industry expertise to the board, an industry that is recognized as one of the largest global market opportunities for Identiv IoT products and services.
"We are excited to welcome Laura and Richard to the Identiv Board of Directors," said James Ousley, chairman of the board. "They each bring substantial knowledge and experience in business transformation, growth strategies, and championing MedTech's rapidly transforming role in healthcare. We are thrilled to have them join our team as we continue to secure our next stage of IoT growth, particularly in the strategic healthcare and pharmaceutical markets."
A series of technological and cultural changes are allowing technology and people to connect through a network of smart devices communicating with each other to automate information exchange and tasks. This is the IoT, and RFID is a key building block of the architecture connecting the digital and physical world.
Identiv's RFID-enabled IoT solutions are integrated into more than 1.5 billion physical "things", creating a digital identity for every physical object and delivering digital transformation across industries. With the rise in demand for a more connected and sophisticated healthcare system within the IoT, the healthcare industry is core to Identiv's growth strategy.
During her 25-year tenure with Johnson & Johnson, Angelini led organizations across Europe and North America, managing exponential acceleration in MedTech. She scaled businesses across global functions, led strategy design for profitability and market leading performance, and created innovation strategies for digital transformation. She stepped down from her position with Baxter in 2021.
"Creating a digital identity for every physical object is the key to digital transformation. RFID is essential to the effectiveness of the IoT, creating the connective foundation," said Angelini. "With Identiv's RFID-enabled solutions laser-focused on the current and future state of the IoT and its potential applications for the healthcare industry, it's an exciting time to join the Board."
Dr. Kuntz joins the board following his most recent role as SVP and chief medical and scientific officer with Medtronic. He has more than 20 years' experience as a leader in MedTech, including his previous role as president of Medtronic Neuromodulation.
Prior to Medtronic, Dr. Kuntz worked as an associate professor, medicine, and chief, clinical biometrics at Harvard Medical School. He is the founder and former chief scientific officer of the Harvard Clinical Research Institute.
"Like the healthcare sector, most industries are increasingly realizing the transformative power of connecting devices with IoT technology," said Dr. Kuntz. "I'm looking forward to working with the Identiv Board and leadership team to help guide the company's assertive growth plan."
"Laura and Richard are outstanding additions to our Board of Directors. Their passion for IoT-enabled healthcare, their reputations in the industry and their experience driving the adoption of transformational technologies in the healthcare industry are perfectly aligned with our vision and growth strategy." said Steven Humphreys, CEO.
Directors Nina Shapiro and Robin Braun will retire from the board this month.
"Nina joined the Board at a critical inflection point and has helped steer its direction through two terms over seven years. Her financial and operational contributions to our plans have been important to our strong execution," said Ousley. "Robin's deep federal leadership experience in government defense, brought new insights to our approach. We are grateful to both Nina and Robin for their contributions to our success."
"We are excited to welcome Laura and Richard to the Identiv Board of Directors," said James Ousley, chairman of the board. "They each bring substantial knowledge and experience in business transformation, growth strategies, and championing MedTech's rapidly transforming role in healthcare. We are thrilled to have them join our team as we continue to secure our next stage of IoT growth, particularly in the strategic healthcare and pharmaceutical markets."
A series of technological and cultural changes are allowing technology and people to connect through a network of smart devices communicating with each other to automate information exchange and tasks. This is the IoT, and RFID is a key building block of the architecture connecting the digital and physical world.
Identiv's RFID-enabled IoT solutions are integrated into more than 1.5 billion physical "things", creating a digital identity for every physical object and delivering digital transformation across industries. With the rise in demand for a more connected and sophisticated healthcare system within the IoT, the healthcare industry is core to Identiv's growth strategy.
About Identiv's New Board Members
Angelini was appointed GM, Global Business Unit, Renal Care at Baxter Healthcare International in 2016 after serving as the global platform leader, joints, at DePuy Synthes Companies of Johnson & Johnson.During her 25-year tenure with Johnson & Johnson, Angelini led organizations across Europe and North America, managing exponential acceleration in MedTech. She scaled businesses across global functions, led strategy design for profitability and market leading performance, and created innovation strategies for digital transformation. She stepped down from her position with Baxter in 2021.
"Creating a digital identity for every physical object is the key to digital transformation. RFID is essential to the effectiveness of the IoT, creating the connective foundation," said Angelini. "With Identiv's RFID-enabled solutions laser-focused on the current and future state of the IoT and its potential applications for the healthcare industry, it's an exciting time to join the Board."
Dr. Kuntz joins the board following his most recent role as SVP and chief medical and scientific officer with Medtronic. He has more than 20 years' experience as a leader in MedTech, including his previous role as president of Medtronic Neuromodulation.
Prior to Medtronic, Dr. Kuntz worked as an associate professor, medicine, and chief, clinical biometrics at Harvard Medical School. He is the founder and former chief scientific officer of the Harvard Clinical Research Institute.
"Like the healthcare sector, most industries are increasingly realizing the transformative power of connecting devices with IoT technology," said Dr. Kuntz. "I'm looking forward to working with the Identiv Board and leadership team to help guide the company's assertive growth plan."
"Laura and Richard are outstanding additions to our Board of Directors. Their passion for IoT-enabled healthcare, their reputations in the industry and their experience driving the adoption of transformational technologies in the healthcare industry are perfectly aligned with our vision and growth strategy." said Steven Humphreys, CEO.
Directors Nina Shapiro and Robin Braun will retire from the board this month.
"Nina joined the Board at a critical inflection point and has helped steer its direction through two terms over seven years. Her financial and operational contributions to our plans have been important to our strong execution," said Ousley. "Robin's deep federal leadership experience in government defense, brought new insights to our approach. We are grateful to both Nina and Robin for their contributions to our success."
